Zhang Wei, Sheng Yayun, Yu Shouqiang, Zhang Chen, Chai Huiping, Liu Feng, Zhu Shaojin, Du Wen
Department of Thoracic Surgery, North District, First Affiliated Hospital of Anhui Medical University (Anhui Provincial Clinical Centre for Public Health), Hefei, China.
Department of Thoracic Surgery, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, China.
J Laparoendosc Adv Surg Tech A. 2025 Sep;35(9):726-734. doi: 10.1089/lap.2025.0075. Epub 2025 Jul 9.
Esophageal squamous cell carcinoma (ESCC) located at the cervicothoracic junction (CTJ-ESCC), approximately 18-21 cm from the incisors, poses unique surgical difficulties given its proximity to the trachea and recurrent laryngeal nerves. This investigation evaluated a new approach that avoids cervical incisions by combining the EGIARADMT™ curvilinear stapling method with OrVil™-based three-dimensional suspension anastomosis (TriSAS) to achieve R0 resection. A retrospective analysis was performed on 11 consecutive cases of CTJ-ESCC treated between February 2019 and March 2024, with follow-up data available until February 2025. All patients underwent R0 resection without cervical incisions, achieving a proximal margin of 1-4 cm. The median operative time was 350 minutes (range: 275-605) with a blood loss of 100 mL (range: 20-700). Lymphadenectomy resulted in a median of 21 nodes (range: 9-38) being retrieved. The median duration of hospitalization was 49 days (range: 42-67). There were no occurrences of anastomotic leaks, strictures, or recurrent laryngeal nerve injuries. Transient gastric stasis was observed in 18.2% of cases and resolved with conservative management. One postoperative mortality was attributed to pulmonary infection. The median overall and disease-free survival were 25 months. Integrating EGIARADMT curvilinear stapling with OrVil-TriSAS anastomosis enables cervical incision-free R0 resection for CTJ-ESCC, achieving precise oncologic control with functional preservation. Adjuvant therapy may further improve survival despite clear margins.
位于颈胸交界处的食管鳞状细胞癌(CTJ-ESCC),距离门齿约18-21厘米,由于其靠近气管和喉返神经,带来了独特的手术困难。本研究评估了一种新方法,即通过将EGIARADMT™曲线吻合器方法与基于OrVil™的三维悬吊吻合术(TriSAS)相结合,避免颈部切口,以实现R0切除。对2019年2月至2024年3月期间连续治疗的11例CTJ-ESCC患者进行回顾性分析,随访数据截至2025年2月。所有患者均在无颈部切口的情况下完成R0切除,近端切缘为1-4厘米。中位手术时间为350分钟(范围:275-605分钟),失血量为100毫升(范围:20-700毫升)。淋巴结清扫中位取出21枚淋巴结(范围:9-38枚)。中位住院时间为49天(范围:42-67天)。未发生吻合口漏、狭窄或喉返神经损伤。18.2%的病例观察到短暂性胃潴留,经保守治疗后缓解。1例术后死亡归因于肺部感染。中位总生存期和无病生存期为25个月。将EGIARADMT曲线吻合术与OrVil-TriSAS吻合术相结合,能够对CTJ-ESCC进行无颈部切口的R0切除,在保留功能的同时实现精确的肿瘤学控制。尽管切缘清晰,但辅助治疗可能进一步提高生存率。